ArticleFrontiers in immunology2024

CD5 blockade, a novel immune checkpoint inhibitor, enhances T cell anti-tumour immunity and delays tumour growth in mice harbouring poorly immunogenic 4T1 breast tumour homografts.

Faizah M Alotaibi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.